Publications in High Impact Factor Journals FY '2022

Share

library

The following publications were co-authored by faculty, residents, or affiliates of the Department of Surgery, and were published within the fiscal year of 2022 in peer-reviewed journals with impact factors of 35 or higher. The names of Duke faculty, residents, or affiliates are highlighted in bold.

 

  1. The long-term sequelae of COVID-19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease.
    Adeloye D, Elneima O, Daines L, Poinasamy K, Quint JK, Walker S, Brightling CE, Siddiqui S, Hurst JR, Chalmers JD, Pfeffer PE, Novotny P, Drake TM, Heaney LG, Rudan I, Sheikh A, De Soyza A, Adeloye D, Elneima O, Daines L, Poinasamy K, Quint JK, Walker S, Brightling CE, Siddiqui S, Hurst JR, Chalmers JD, Pfeffer PE, Novotny P, Drake TM, Abdollahi M, Agarwal D, Al-Lehebi R, Barnes PJ, Bayry J, Bonay M, Bont LJ, Bourdin A, Brown T, Caramori G, Chan AHY, Dockrell DH, Doe S, Duckers J, D’Urzo A, Ekström M, Esteban C, Greene CM, Gupta A, Ingram JL, Khoo EM, Ko FWS, Koppelman GH, Lipworth BJ, Lisspers K, Loebinger M, Lopez-Campos JL, Maddocks M, Mannino D, Martinez-Garcia MA, Mcnamara R, Miravitlles M, Ndarukwa P, Pooler A, Rhee CK, Schwarz P, Shaw D, Steiner M, Tai A, Ulrik CS, Walker P, Williams MC, Heaney LG, Rudan I, Sheikh A, De Soyza A. The Lancet Respiratory Medicine. 2021;9(12):1467-1478.
     
  2. Boosting immunity to Omicron. 
    Shen X. Nature Medicine. 2022;28(3):445-446. 
     
  3. Immune response to SARS-CoV-2 after a booster of mRNA-1273: an open-label phase 2 trial.
    Chu L, Vrbicky K, Montefiori D, Huang W, Nestorova B, Chang Y, Carfi A, Edwards DK, Oestreicher J, Legault H, Dutko FJ, Girard B, Pajon R, Miller JM, Das R, Leav B, McPhee R. Nature Medicine. 2022;28(5):1042-1049.
     
  4. Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition. 
    Gilbert PB, Huang Y, DeCamp AC, Karuna S, Zhang Y, Magaret CA, Giorgi EE, Korber B, Edlefsen PT, Rossenkhan R, Juraska M, Rudnicki E, Kochar N, Huang Y, Carpp LN, Barouch DH, Mkhize NN, Hermanus T, Kgagudi P, Bekker V, Kaldine H, Mapengo RE, Eaton A, Domin E, West C, Feng W, Tang H, Seaton KE, Heptinstall J, Brackett C, Chiong K, Tomaras GD, Andrew P, Mayer BT, Reeves DB, Sobieszczyk ME, Garrett N, Sanchez J, Gay C, Makhema J, Williamson C, Mullins JI, Hural J, Cohen MS, Corey L, Montefiori DC, Morris L. Nature Medicine. 2022;28(9):1924-1932.
     
  5. Safety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1: a phase 1 clinical trial.
    Julg B, Stephenson KE, Wagh K, Tan SC, Zash R, Walsh S, Ansel J, Kanjilal D, Nkolola J, Walker-Sperling VEK, Ophel J, Yanosick K, Borducchi EN, Maxfield L, Abbink P, Peter L, Yates NL, Wesley MS, Hassell T, Gelderblom HC, DeCamp A, Mayer BT, Sato A, Gerber MW, Giorgi EE, Gama L, Koup RA, Mascola JR, Monczor A, Lupo S, Rolle C-P, Arduino R, DeJesus E, Tomaras GD, Seaman MS, Korber B, Barouch DH. Nature Medicine. 2022;28(6):1288-1296. 
     
  6. Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis.
    Choi A, Koch M, Wu K, Chu L, Ma L, Hill A, Nunna N, Huang W, Oestreicher J, Colpitts T, Bennett H, Legault H, Paila Y, Nestorova B, Ding B, Montefiori D, Pajon R, Miller JM, Leav B, Carfi A, McPhee R, Edwards DK. Nature Medicine. 2021;27(11):2025-2031.
     
  7. Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trial. 
    Casazza JP, Cale EM, Narpala S, Yamshchikov GV, Coates EE, Hendel CS, Novik L, Holman LA, Widge AT, Apte P, Gordon I, Gaudinski MR, Conan-Cibotti M, Lin BC, Nason MC, Trofymenko O, Telscher S, Plummer SH, Wycuff D, Adams WC, Pandey JP, McDermott A, Roederer M, Sukienik AN, O’Dell S, Gall JG, Flach B, Terry TL, Choe M, Shi W, Chen X, Kaltovich F, Saunders KO, Stein JA, Doria-Rose NA, Schwartz RM, Balazs AB, Baltimore D, Nabel GJ, Koup RA, Graham BS, Ledgerwood JE, Mascola JR, Andrews C, Arthur A, Awan SF, Beck A, Burch E, Burgos Florez MC, Berkowitz NM, Boritz EA, Carlton K, Cartagena CT, Carter C, Chen GL, Costner P, Cunningham J, Douek DC, Eshun AM, Evans C, Hicks R, Houser KV, Jones J, Larkin B, Le L, Mendoza F, Migueles S, Misasi J, Nguyen TA, Ola A, Parker K, Pittman I, Requilman LS, Rothwell RS, Schieber GL, Saunders J, Sitar S, Tran C, Trofymenko O, Vasilenko O, Waheed S, Wang L, Wang X, Whalen W, Williams P, Wu RL, Zephir K. Nature Medicine. 2022;28(5):1022-1030.
     
  8. Safety, pharmacokinetics and antiviral activity of PGT121, a broadly neutralizing monoclonal antibody against HIV-1: a randomized, placebo-controlled, phase 1 clinical trial.
    Stephenson KE, Julg B, Tan CS, Zash R, Walsh SR, Rolle C-P, Monczor AN, Lupo S, Gelderblom HC, Ansel JL, Kanjilal DG, Maxfield LF, Nkolola J, Borducchi EN, Abbink P, Liu J, Peter L, Chandrashekar A, Nityanandam R, Lin Z, Setaro A, Sapiente J, Chen Z, Sunner L, Cassidy T, Bennett C, Sato A, Mayer B, Perelson AS, DeCamp A, Priddy FH, Wagh K, Giorgi EE, Yates NL, Arduino RC, DeJesus E, Tomaras GD, Seaman MS, Korber B, Barouch DH. Nature Medicine. 2021;27(10):1718-1724.
     
  9. Defining the risk of SARS-CoV-2 variants on immune protection. 
    DeGrace MM, Ghedin E, Frieman MB, Krammer F, Grifoni A, Alisoltani A, Alter G, Amara RR, Baric RS, Barouch DH, Bloom JD, Bloyet L-M, Bonenfant G, Boon ACM, Boritz EA, Bratt DL, Bricker TL, Brown L, Buchser WJ, Carreño JM, Cohen-Lavi L, Darling TL, Davis-Gardner ME, Dearlove BL, Di H, Dittmann M, Doria-Rose NA, Douek DC, Drosten C, Edara V-V, Ellebedy A, Fabrizio TP, Ferrari G, Fischer WM, Florence WC, Fouchier RAM, Franks J, García-Sastre A, Godzik A, Gonzalez-Reiche AS, Gordon A, Haagmans BL, Halfmann PJ, Ho DD, Holbrook MR, Huang Y, James SL, Jaroszewski L, Jeevan T, Johnson RM, Jones TC, Joshi A, Kawaoka Y, Kercher L, Koopmans MPG, Korber B, Koren E, Koup RA, LeGresley EB, Lemieux JE, Liebeskind MJ, Liu Z, Livingston B, Logue JP, Luo Y, McDermott AB, McElrath MJ, Meliopoulos VA, Menachery VD, Montefiori DC, Mühlemann B, Munster VJ, Munt JE, Nair MS, Netzl A, Niewiadomska AM, O'Dell S, Pekosz A, Perlman S, Pontelli MC, Rockx B, Rolland M, Rothlauf PW, Sacharen S, Scheuermann RH, Schmidt SD, Schotsaert M, Schultz-Cherry S, Seder RA, Sedova M, Sette A, Shabman RS, Shen X, Shi P-Y, Shukla M, Simon V, Stumpf S, Sullivan NJ, Thackray LB, Theiler J, Thomas PG, Trifkovic S, Türeli S, Turner SA, Vakaki MA, van Bakel H, VanBlargan LA, Vincent LR, Wallace ZS, Wang L, Wang M, Wang P, Wang W, Weaver SC, Webby RJ, Weiss CD, Wentworth DE, Weston SM, Whelan SPJ, Whitener BM, Wilks SH, Xie X, Ying B, Yoon H, Zhou B, Hertz T, Smith DJ, Diamond MS, Post DJ, Suthar MS. Nature, 2022;605(7911), 640–652.
     
  10. Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study.
    Hastie KM, Li H, Bedinger D, Schendel SL, Dennison SM, Li K, Rayaprolu V, Yu X, Mann C, Zandonatti M, Diaz Avalos R, Zyla D, Buck T, Hui S, Shaffer K, Hariharan C, Yin J, Olmedillas E, Enriquez A, Parekh D, Abraha M, Feeney E, Horn GQ, Aldon Y, Ali H, Aracic S, Cobb RR, Federman RS, Fernandez JM, Glanville J, Green R, Grigoryan G, Lujan Hernandez AG, Ho DD, Huang K-YA, Ingraham J, Jiang W, Kellam P, Kim C, Kim M, Kim HM, Kong C, Krebs SJ, Lan F, Lang G, Lee S, Leung CL, Liu J, Lu Y, MacCamy A, McGuire AT, Palser AL, Rabbitts TH, Rikhtegaran Tehrani Z, Sajadi MM, Sanders RW, Sato AK, Schweizer L, Seo J, Shen B, Snitselaar JL, Stamatatos L, Tan Y, Tomic MT, Van Gils MJ, Youssef S, Yu J, Yuan TZ, Zhang Q, Peters B, Tomaras GD, Germann T, Saphire EO. (2021). Science. 2021;374(6566):472-478.
     
  11. Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity.
    Gobeil SM-C, Janowska K, McDowell S, Mansouri K, Parks R, Stalls V, Kopp MF, Manne K, Li D, Wiehe K, Saunders KO, Edwards RJ, Korber B, Haynes BF, Henderson R, Acharya P. Science. 2021;373(6555). 
     
  12. Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial. 
    Gilbert PB, Montefiori DC, McDermott AB, Fong Y, Benkeser D, Deng W, Zhou H, Houchens CR, Martins K, Jayashankar L, Castellino F, Flach B, Lin BC, O’Connell S, McDanal C, Eaton A, Sarzotti-Kelsoe M, Lu Y, Yu C, Borate B, Van der Laan LWP, Hejazi NS, Huynh C, Miller J, El Sahly HM, Baden LR, Baron M, De La Cruz L, Gay C, Kalams S, Kelley CF, Andrasik MP, Kublin JG, Corey L, Neuzil KM, Carpp LN, Pajon R, Follmann D, Donis RO, Koup RA. Science. 2022;375(6576):43-50.
     
  13. Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates.
    Corbett KS, Nason MC, Flach B, Gagne M, O’Connell S, Johnston TS, Shah SN, Edara VV, Floyd K, Lai L, McDanal C, Francica JR, Flynn B, Wu K, Choi A, Koch M, Abiona OM, Werner AP, Moliva JI, Andrew SF, Donaldson MM, Fintzi J, Flebbe DR, Lamb E, Noe AT, Nurmukhambetova ST, Provost SJ, Cook A, Dodson A, Faudree A, Greenhouse J, Kar S, Pessaint L, Porto M, Steingrebe K, Valentin D, Zouantcha S, Bock KW, Minai M, Nagata BM, Van de Wetering R, Boyoglu-Barnum S, Leung K, Shi W, Yang ES, Zhang Y, Todd J-PM, Wang L, Alvarado GS, Andersen H, Foulds KE, Edwards DK, Mascola JR, Moore IN, Lewis MG, Carfi A, Montefiori D, Suthar MS, McDermott A, Roederer M, Sullivan NJ, Douek DC, Graham BS, Seder RA. Science. 2021;373(6561).
     
  14. Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study.
    COVIDSurg Collaborative. The Lancet Oncology. 2021;22(11):1507-1517.
     
  15. Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (Galahad): A multicentre, open-label, phase 2 trial.
    Smith MR, Scher HI, Sandhu S, Efstathiou E, Lara PN, Yu EY, George DJ, Chi KN, Saad F, Ståhl O, Olmos D, Danila DC, Mason GE, Espina BM, Zhao X, Urtishak KA, Francis P, Lopez-Gitlitz A, Fizazi K, GALAHAD investigators. The Lancet Oncology. 2002;23(3):362-373.
     
  16. Clinical trials for metastatic castrate-resistant prostate cancer-who is looking after the control patients? Questions for the future.
    Ardolino L, Dear R, Armstrong A, Gillessen S, Joshua A. Annals of Oncology. 2022;33(6):574-577.
     
  17. Elevating the Patient Voice in Metastatic Hormone-Sensitive Prostate Cancer Clinical Trials. 
    Dzimitrowicz HE, Armstrong AJ. Journal of Clinical Oncology. 2022;40(8):807-810.
     
  18. Genetic Counseling and Testing in African American Patients With Breast Cancer: A Nationwide Survey of US Breast Oncologists.
    Ademuyiwa FO, Salyer P, Tao Y, Luo J, Hensing WL, Afolalu A, Peterson LL, Weilbaecher K, Housten AJ, Baumann AA, Desai M, Jones S, Linnenbringer E, Plichta J, Bierut L. Journal of Clinical Oncology. 2021;39(36):4020-4028.
     
  19. Improved Survival With Enzalutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer.
    Armstrong AJ, Azad AA, Iguchi T, Szmulewitz RZ, Petrylak DP, Holzbeierlein J, Villers A, Alcaraz A, Alekseev B, Shore ND, Gomez-Veiga F, Rosbrook B, Zohren F, Yamada S, Haas GP, Stenzl A. Journal of Clinical Oncology. 2022;40(15):1616-1622. 
     
  20. More Than Incremental: Harnessing Machine Learning to Predict Breast Cancer Risk.
    Grimm LJ, Plichta JK, Hwang ES. Journal of Clinical Oncology. 2022;40(16):1713-1717.
     
  21. Phase II Study of Gemcitabine and Split-Dose Cisplatin Plus Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Bladder Cancer.
    Rose TL, Harrison MR, Deal AM, Ramalingam S, Whang YE, Brower B, Dunn M, Osterman CK, Heiling HM, Bjurlin MA, Smith AB, Nielsen ME, Tan H-J, Wallen E, Woods ME, George D, Zhang T, Drier A, Kim WY, Milowsky MI. Journal of Clinical Oncology. 2021;39(28):3140-3148.
     
  22. Prospective Evaluation of Clinical Outcomes Using a Multiplex Liquid Biopsy Targeting Diverse Resistance Mechanisms in Metastatic Prostate Cancer.
    Sperger JM, Emamekhoo H, McKay RR, Stahlfeld CN, Singh A, Chen XE, Kwak L, Gilsdorf CS, Wolfe SK, Wei XX, Silver R, Zhang Z, Morris MJ, Bubley G, Feng FY, Scher HI, Rathkopf D, Dehm SM, Choueiri TK, Halabi S, Armstrong AJ, Wyatt AW, Taplin M-E, Zhao SG, Lang JM. Journal of Clinical Oncology. 2021;39(26):2926-2937.
     
  23. Reply to M. K. Bos et al.
    Sperger JM, Feng FY, Armstrong AJ, Zhao SG, Lang JM. Journal of Clinical Oncology. 2022;40(5):520-522.
     
  24. How to train your antibody to fight malaria.
    Stalls V, Acharya P.  Immunity. 2021;54(12):2692-2694.
     
  25. Primary germinal center-resident T follicular helper cells are a physiologically distinct subset of CXCR5hiPD-1hi T follicular helper cells
    Yeh C-H, Finney J, Okada T, Kurosaki T, Kelsoe G. Immunity. 2022;55(2):272-289.e7.
     
  26. Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancer.
    Lips EH, Kumar T, Megalios A, Visser LL, Sheinman M, Fortunato A, Shah V, Hoogstraat M, Sei E, Mallo D, Roman-Escorza M, Ahmed AA, Xu M, Van den Belt-Dusebout AW, Brugman W, Casasent AK, Clements K, Davies HR, Fu L, Grigoriadis A, Hardman TM, King LM, Krete M, Kristel P, De Maaker M, Maley CC, Marks JR, Menegaz BA, Mulder L, Nieboer F, Nowinski S, Pinder S, Quist J, Salinas-Souza C, Schaapveld M, Schmidt MK, Shaaban AM, Shami R, Sridharan M, Zhang J, Stobart H, Collyar D, Nik-Zainal S, Wessels LFA, Hwang ES, Navin NE, Futreal PA, Futreal PA, Hwang ES, Jonkers J, Jacco, Behbod F, Rea D, Bhattacharjee P, Pinto D, Verschuur E, Van Oirsouw M, Thompson AM, Wesseling J, Sawyer EJ. Nature Genetics. 2022;54(6):850-860.
     
  27. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, Bischoff JM, Bittl JA, Cohen MG, DiMaio JM, Don CW, Fremes SE, Gaudino MF, Goldberger ZD, Grant MC, Jaswal JB, Kurlansky PA, Mehran R, Metkus TS, Nnacheta LC, Rao SV, Sellke FW, Sharma G, Yong CM, Zwischenberger BA. Circulation. 2022;145(3).
     
  28. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. 
    Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, Bischoff JM, Bittl JA, Cohen MG, DiMaio JM, Don CW, Fremes SE, Gaudino MF, Goldberger ZD, Grant MC, Jaswal JB, Kurlansky PA, Mehran R, Metkus TS, Nnacheta LC, Rao SV, Sellke FW, Sharma G, Yong CM, Zwischenberger BA. Circulation. 2022;145(3). 
     
  29. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, Nnacheta LC, Sandhu AT, Stevenson LW, Vardeny O, Vest AR, Yancy CW. Circulation. 2022;145(18).
     
  30. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, Nnacheta LC, Sandhu AT, Stevenson LW, Vardeny O, Vest AR, Yancy CW. Circulation. 2022;145(18).
     
  31. Abstract 12181: Targeted intra-coronary delivery versus intra-myocardial injection of therapeutics for myocardial recovery: A nanoparticle image guided porcine study.
    Vekstein AM, Wendell DC, Bowles DE, DeLuca S, Yan R, Bishawi M, Devlin G, Asokan A, Poss KD, Bursac N, Williams AR. Circulation. 2021;144.
     
  32. Cardiac Surgery in Women in the Current Era: What Are the Gaps in Care?
    Cho L, Kibbe MR, Bakaeen F, Aggarwal NR, Davis MB, Karmalou T, Lawton JS, Ouzounian M, Preventza O, Russo AM, Shroyer A-LW, Zwischenberger BA, Lindley KJ. Circulation. 2021;144(14):1172-1185. 
     
  33. Methodological standards for the design, implementation, and analysis of randomized trials in cardiac surgery: A scientific statement from the American Heart Association.
    Gaudino M, Chikwe J, Bagiella E, Bhatt DL, Doenst T, Fremes SE, Lawton J, Masterson Creber RM, Sade RM, Zwischenberger BA. Circulation. 2022;145(4).
     
  34. Prognostication of Asymptomatic Penetrating Aortic Ulcers: A Modern Approach.
    DeCarlo C, Latz CA, Boitano LT, Kim Y, Tanious A, Schwartz SI, Patell R, Mohebali J, Dua A. Circulation. 2021;144(14):1091-1101.
     
  35. Cancer vaccines. 
    Schiller JT, Lowy DR, Frazer IH, Finn OJ, Vilar E, Lyerly HK, Gnjatic S, Zaidi N, Ott PA, Balachandran VP, Dietrich P-Y, Migliorini D, Vonderheide RH, Domchek SM. Cancer Cell. 2022;40(6):559-564.
     
  36. Epigenetic STING silencing is developmentally conserved in gliomas and can be rescued by methyltransferase inhibition. 
    Low JT, Chandramohan V, Bowie ML, Brown MC, Waitkus MS, Briley A, Stevenson K, Fuller R, Reitman ZJ, Muscat AM, Hariharan S, Hostettler J, Danehower S, Baker A, Khasraw M, Wong NC, Gregory S, Nair SK, Heimberger A, Gromeier M, Bigner DD, Ashley DM. Cancer Cell. 2022;40(5):439-440.
     
  37. Corrigendum to: Mild cognitive impairment in middle-aged adults with coronary microvascular dysfunction.
    Nowroozpoor A, Sharp E, Gordon R, Malicki C, Hwang U, Dziura J, D’Onofrio’ G, Safdar B. European Heart Journal. 2021;43(18):1776-1776.

 

Share